Which one of the following statements best describes your approach to prescribing a new treatment in your patients with EGPA?I am likely to be among the first to prescribe a new treatment once it is approvedI am likely to prescribe a new treatment as soon as credible clinical trial data becomes availableI am likely to prescribe a new treatment as soon as credible long-term clinical trial data becomes availableI am likely to prescribe a new treatment as soon as credible Real-World Evidence (RWE) becomes availableI am likely to prescribe a new treatment only after specialists or key opinion leaders (KOLs) recommend itI am likely to prescribe a new treatment only after my colleagues have had clinical experience with itI am likely to prescribe a new treatment only after treatment guidelines have recommended itI am likely to prescribe a new treatment only after it is listed on hospital formularies / is reimbursedYou said that you would likely prescribe a new treatment as soon as credible long-term clinical trial data became available.How many years would you expect “long-term clinical data” to cover?